Illumina, Inc.
NASDAQ:ILMNMedical - Diagnostics & Research
+$1.95 today
- Market cap
- $31.75B
- Beta
- 1.49
- P/E (TTM)
- 28.9
- EPS (TTM)
- $5.58
Volume 1.63M
Average 1.65M
ILMN Account Payables
Amounts the company owes suppliers for goods and services received.
Illumina, Inc.NASDAQ: ILMN
Account Payables · Q2 FY2026 · quarter ended Jun 2026
Account payables rises 15.0% from a year ago
Account payables stood at $230M at the end of Q2 FY2026, up 15.0% from a year earlier and up 5.5% from the prior quarter. Over 3 fiscal years it compounded at -6.4% a year.
Context
- Account payables amounted to 3.5% of total assets at the end of Q2 FY2026, up 0.2 pp from a year earlier.
- Account payables increased in 1 of the last 3 fiscal years.
What to watch
Whether account payables keeps rising in the next quarterly balance sheet after a +15.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Account Payables history
USD · from the balance sheet
- Latest · FY2025
- 240M USD
- Year-over-year change
- +8.6%
- 4-year CAGR
- -7.8%
| Period | Period end | Account Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-28 | 240M | +8.6% |
| FY2024 | 2024-12-29 | 221M | -9.8% |
| FY2023 | 2023-12-31 | 245M | -16.4% |
| FY2022 | 2023-01-01 | 293M | -11.7% |
| FY2021 | 2022-01-02 | 332M | — |
Account Payables vs competitors
How ILMN compares with its peers on the latest reported figures
- ILMN's Jun 2026 account payables of $230M is the highest of the 11 companies compared; the peer median is $17.6M.
- Its year-over-year change of +15.0% is the 10th highest of 11, against a peer median of +56.9%.
- Account payables amounts to 3.5% of total assets for ILMN, versus a peer median of 3.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $230M | +15.0% | -6.4% | 3.5% | |
| Sep 2026 | $102.51M | +408.9% | -7.6% | 5.4% | |
| Jun 2026 | $100.46M | +265.4% | +4.0% | 7.4% | |
| Jun 2026 | $75.15M | +103.8% | +2.1% | 2.8% | |
| Mar 2026 | $32.6M | +16.0% | +1.4% | 4.8% | |
| Sep 2026 | $21.59M | +19.5% | -16.2% | 2.0% | |
| Mar 2026 | $13.61M | -3.0% | +20.0% | 1.7% | |
| Mar 2026 | $12.68M | +60.2% | +0.3% | 3.9% | |
| Mar 2026 | $12.67M | +175.0% | +34.8% | 8.1% | |
BLLNBillionToOne, Inc. | Jun 2026 | $12.21M | +53.6% | — | 1.7% |
WGSGeneDx Holdings Corp. | Jun 2026 | $5.15M | +46.1% | -62.3% | 1.1% |
| Peer median (excluding ILMN) | $17.6M | +56.9% | +1.4% | 3.4% | |
Competitors are the stored peer set for ILMN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Jan 2022 | FY2022 Jan 2023 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.23B | 2.01B | 1.05B | 1.13B | 1.42B |
| Short-term Investments | 107M | 26M | 6M | 93M | 215M |
| Net Receivables | 664M | 688M | 752M | 751M | 854M |
| Inventory | 431M | 568M | 587M | 547M | 564M |
| Other Current Assets | 0 | 268M | 216M | 228M | 238M |
| Total Current Assets | 2.71B | 3.56B | 2.61B | 2.75B | 3.29B |
| Property, Plant & Equipment (Net) | 1.7B | 1.74B | 1.55B | 1.23B | 1.13B |
| Goodwill | 7.11B | 3.24B | 2.55B | 1.11B | 1.11B |
| Intangible Assets | 3.25B | 3.29B | 2.99B | 295M | 210M |
| Long-term Investments | 213M | 211M | 196M | 227M | 338M |
| Tax Assets | 0 | 0 | 0 | 567M | 454M |
| Other Non-current Assets | 232M | 212M | 217M | 121M | 111M |
| Total Non-current Assets | 12.5B | 8.69B | 7.5B | 3.56B | 3.36B |
| Total Assets | 15.22B | 12.25B | 10.11B | 6.3B | 6.64B |
| Account Payables | 332M | 293M | 245M | 221M | 240M |
| Short-term Debt | 0 | 1.25B | 0 | 578M | 499M |
| Tax Payables | 98M | 97M | 79M | 101M | 0 |
| Deferred Revenue | 234M | 245M | 252M | 260M | 270M |
| Other Current Liabilities | 241M | 188M | 223M | 70M | 249M |
| Total Current Liabilities | 1.09B | 2.77B | 1.57B | 1.55B | 1.59B |
| Long-term Debt | 1.7B | 1.49B | 1.49B | 1.49B | 1.49B |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 67M | 0 |
| Other Non-current Liabilities | 915M | 649M | 620M | 272M | 360M |
| Total Non-current Liabilities | 3.38B | 2.88B | 2.8B | 2.38B | 2.34B |
| Total Liabilities | 4.48B | 5.65B | 4.37B | 3.93B | 3.92B |
| Common Stock | 2M | 2M | 2M | 2M | 2M |
| Retained Earnings | 5.49B | 1.14B | (19M) | (1.24B) | (392M) |
| Accumulated OCI | 17M | 3M | (1M) | 22M | (10M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 10.74B | 6.6B | 5.75B | 2.37B | 2.72B |
| Total Debt | 2.54B | 3.56B | 2.26B | 2.62B | 2.55B |
| Net Debt | 1.31B | 1.54B | 1.21B | 1.5B | 1.14B |
Illumina, Inc.
NASDAQ:ILMN
Intrinsic Alpha fair value
Locked
Current Price
$210.01
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.